VM-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VM-001, covering 2022-03-11 to 2022-03-11. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective, Open Label, Dose-escalation, SAD/MAD, Multicenter, 24weeks, Phase I/IIa Clinical Trial to Evaluate the Safety, Tolerability and Pharmacodynamics of Investigational Product (VM-001) in Patients With Graft-versus-host Disease(GvHD) [Phase 1, Phase 2]